source
- BioMarin's Phase 3 trial of ENPP1 enzyme therapy fails to show benefitBioMarin reported that its late-stage study of an enzyme replacement therapy for ENPP1 deficiency did not meet its primary efficacy endpoints. The trial, which enrolled patients lacking the ENPP1 e…
- Over 1 in 8 U.S. Pregnant Women Report Alcohol Use, Raising Fetal Health ConcernsMore than one in eight pregnant adults in the United States reported drinking in the past month, according to STAT's analysis of 2024 government data, making alcohol use more common than gestationa…